Analysts: Arena Pharmaceuticals Inc (ARNA.OQ)
ARNA.OQ on NASDAQ Stock Exchange Global Select Market
6.87USD
1 Aug 2013
6.87USD
1 Aug 2013
Price Change (% chg)
$-0.08 (-1.15%)
$-0.08 (-1.15%)
Prev Close
$6.95
$6.95
Open
$7.15
$7.15
Day's High
$7.15
$7.15
Day's Low
$6.82
$6.82
Volume
1,296,797
1,296,797
Avg. Vol
1,064,672
1,064,672
52-wk High
$10.99
$10.99
52-wk Low
$6.65
$6.65
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | -0.07 | December | 1 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 1 | 1 | 1 | 1 |
| (3) HOLD | 6 | 6 | 6 | 6 |
| (4) UNDERPERFORM | 2 | 2 | 2 | 2 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 3.09 | 3.09 | 3.09 | 3.09 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 11 | 12.48 | 66.60 | 4.50 | 19.63 |
| Quarter Ending Dec-13 | 11 | 10.86 | 20.81 | 5.69 | 35.33 |
| Year Ending Dec-13 | 11 | 83.28 | 100.60 | 24.60 | 57.67 |
| Year Ending Dec-14 | 11 | 96.37 | 175.40 | 47.84 | 136.87 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 11 | -0.07 | 0.17 | -0.12 | -0.05 |
| Quarter Ending Dec-13 | 11 | -0.10 | -0.05 | -0.13 | -0.01 |
| Year Ending Dec-13 | 9 | -0.10 | -0.08 | -0.15 | -0.17 |
| Year Ending Dec-14 | 11 | -0.17 | 0.14 | -0.37 | 0.09 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 44.45 | 2.37 | 42.08 | 94.66 |
| Quarter Ending Dec-12 | 17.43 | 1.94 | 15.50 | 88.90 |
| Quarter Ending Sep-12 | 3.51 | 1.49 | 2.03 | 57.69 |
| Quarter Ending Jun-12 | 10.07 | 21.98 | 11.91 | 118.34 |
| Quarter Ending Mar-12 | 2.65 | 2.19 | 0.46 | 17.44 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.09 | -0.09 | 0.18 | 204.17 |
| Quarter Ending Dec-12 | -0.03 | -0.10 | 0.07 | -257.14 |
| Quarter Ending Sep-12 | -0.09 | -0.07 | 0.02 | -18.22 |
| Quarter Ending Jun-12 | -0.07 | -0.12 | 0.05 | -77.78 |
| Quarter Ending Mar-12 | -0.12 | -0.18 | 0.06 | -44.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 12.48 | 12.39 | 12.39 | 12.39 | 19.63 |
| Quarter Ending Dec-13 | 10.86 | 10.81 | 10.81 | 10.81 | 35.33 |
| Year Ending Dec-13 | 83.28 | 82.74 | 82.74 | 82.74 | 57.67 |
| Year Ending Dec-14 | 96.37 | 95.39 | 95.39 | 95.39 | 136.87 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | -0.07 | -0.07 | -0.07 | -0.07 | -0.05 |
| Quarter Ending Dec-13 | -0.10 | -0.10 | -0.10 | -0.10 | -0.01 |
| Quarter Ending Dec-13 | -0.10 | -0.11 | -0.11 | -0.11 | -0.17 |
| Quarter Ending Dec-14 | -0.17 | -0.17 | -0.17 | -0.17 | 0.09 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 1 | 0 | 1 | 0 |
| Quarter Ending Dec-13 | 1 | 0 | 1 | 0 |
| Year Ending Dec-13 | 1 | 0 | 1 | 0 |
| Year Ending Dec-14 | 1 | 0 | 1 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 1 | 0 | 1 | 0 |
| Year Ending Dec-14 | 1 | 0 | 1 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates